Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a relatively rare

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood

Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according

The European Commission approved the drug Velcade (bortezomib) for the treatment of

Next up in the Leukemia & Lymphoma Society's free telephone/web education programs

Mantle cell lymphoma remains one of the more elusive subtypes of

According to an open-label multicenter, phase 2 study coming from the US and Europe, the

Because science has only recently became familiar with mantle cell lymphoma, there aer not

A new study in the New England Journal of Medicine points towards a more tolerable

Mantle cell lymphoma (MCL), a rare disease that has been difficult to study in clinical

Mantle cell lymphoma (MCL) is a very rare and difficult to